Compare iShares MSCI Hong Kong ETF (EWH) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Hong Kong ETF vs Halozyme Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Hong Kong ETF trades at $22.07 (market cap $1.16B), while Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 10.8× iShares MSCI Hong Kong ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 61 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| EWH | HALO | |
|---|---|---|
Market Cap | $1.16B | $12.58B |
Volume | 3,176,523 | 2,179,278 |
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $115.22 |
52-Week Low | $20.66 | $61.63 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | — | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWH, the iShares MSCI Hong Kong ETF, trades at $22.04, up 2.13% in the last 24 hours. The technical outlook is bearish, with moving averages signaling a downtrend and key support at $21. Recent news highlights volatility in the Hang Seng Index, driven by Federal Reserve decisions and geopolitical tensions. Financial ratios are unavailable in the provided data, limiting fundamental assessment.
The ETF faces headwinds from Hong Kong market weakness and institutional selling, but oversold conditions per RSI may offer tactical opportunities. Risks include ongoing U.S.-China tensions and economic pressures. Investors should weigh exposure to Hong Kong equities against broader market risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
